GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (STU:3NK) » Definitions » Tax Rate %

Alphamab Oncology (STU:3NK) Tax Rate % : 0.00% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Alphamab Oncology's Tax Expense for the six months ended in Jun. 2024 was €0.00 Mil. Alphamab Oncology's Pre-Tax Income for the six months ended in Jun. 2024 was €-5.75 Mil. Therefore, Alphamab Oncology's Tax Rate % for the quarter that ended in Jun. 2024 was 0.00%.

Alphamab Oncology Tax Rate % Historical Data

The historical data trend for Alphamab Oncology's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Tax Rate % Chart

Alphamab Oncology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Rate %
Get a 7-Day Free Trial - - - - -

Alphamab Oncology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alphamab Oncology Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Alphamab Oncology's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=0/-27.046
=0.00 %

Alphamab Oncology's Tax Rate % for the quarter that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2024 )/Pre-Tax Income (Q: Jun. 2024 )
=0/-5.749
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alphamab Oncology Tax Rate % Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (STU:3NK) » Definitions » Tax Rate %
Comparable Companies
HKSE:02157 HKSE:01672 HKSE:02171 HKSE:02142 HKSE:02315 HKSE:02105 HKSE:00775 HKSE:02256 HKSE:06660 HKSE:02480 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
09966:Hong Kong
Address
No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215127
Website
https://www.alphamabonc.com
Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in the discovery, development manufacturing, and commercialization of biotherapeutics for cancer treatment. Its product pipeline includes various drug candidates such as KN035 (Envida), KN046, KN026, JSKN003, and KN019 among others in different stages of development.

Alphamab Oncology Headlines

No Headlines